首页> 美国卫生研究院文献>Veterinary Research >Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice
【2h】

Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice

机译:减毒沙门氏菌递送的旋毛虫旋毛虫DNase II DNA疫苗的口服疫苗可诱导BALB / c小鼠产生保护性免疫

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Trichinellosis is one of the most serious foodborne parasitic zoonosis with worldwide distribution, and it is necessary to develop a vaccine to interrupt transmission from animals to humans. Trichinella spiralis adult-specific DNase II-1 (TsDNase II) were identified by immunoproteomics in surface or excretory/secretory proteins of adult worms (AW) and intestinal infective larvae (IIL). The aim of this study was to investigate the systemic, mucosal responses and immune protection elicited by oral vaccination with TsDNase II DNA vaccine delivered by attenuated Salmonella typhimurium strain⊿cyaSL1344. Oral vaccination with TsDNase II DNA vaccine triggered an obvious mucosal sIgA response and a systemic IgG response in mice, and IgG1 was predominant. Th1 (IFN-γ) and Th2 (IL-4, 10) cytokines were distinctly increased in the spleen and mesenteric lymph node (MLN) cells of vaccinated mice. An indirect immunofluorescent test revealed that native TsDNase II is present at the cuticle of this nematode after the 2nd molting, further confirming that TsDNase II is adult-specific and expressed at AW and pre-adult stages. Oral immunization of mice with TsDNase II exhibited a 53.85% reduction in AW and a 59.26% reduction in ML after larval challenge. The in vitro NBL production of adult females from TsDNase II-vaccinated mice was also reduced in comparison with pcDNA3.1 or the PBS control group (P < 0.01). Our results show that oral immunization of mice with TsDNase II produced an intestinal and systematic concurrent Th1/Th2 immune response, and a significant immune protection against challenge.Electronic supplementary materialThe online version of this article (10.1186/s13567-018-0614-y) contains supplementary material, which is available to authorized users.
机译:旋毛虫病是分布最广泛的最严重的食源性寄生虫人畜共患病之一,因此有必要开发一种疫苗来中断从动物到人类的传播。旋毛虫成虫特异性DNase II-1(TsDNase II)通过免疫蛋白质组学鉴定成虫(AW)和肠道感染性幼虫(IIL)的表面或排泄/分泌蛋白。这项研究的目的是调查减毒鼠伤寒沙门氏菌菌株cyaSL1344递送的TsDNase II DNA疫苗的口服疫苗接种引起的全身性,粘膜反应和免疫保护作用。 TsDNase II DNA疫苗的口服疫苗在小鼠中引发了明显的粘膜sIgA反应和全身性IgG反应,其中以IgG1为主导。在接种小鼠的脾脏和肠系膜淋巴结(MLN)细胞中,Th1(IFN-γ)和Th2(IL-4、10)细胞因子明显增加。间接免疫荧光测试表明,在第二次蜕皮后,该线虫的表皮中存在天然的TsDNase II,这进一步证实了TsDNase II是成人特异性的,并在AW和成年前表达。幼虫攻击后,用TsDNase II口服免疫小鼠表现出AW降低53.85%,ML降低59.26%。与pcDNA3.1或PBS对照组相比,TsDNase II疫苗接种的小鼠的成年雌性的体外NBL产量也降低了(P <0.01)。我们的结果表明,用TsDNase II小鼠进行口服免疫可产生肠道和系统性的并发Th1 / Th2免疫应答,并具有显着的免疫挑战性免疫保护。电子补充材料本文的在线版本(10.1186 / s13567-018-0614-y)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号